Upgrade to SI Premium - Free Trial

GSK (GSK) Announces FDA Priority Review for BLA for Adult RSV Vaccine

November 2, 2022 8:37 AM
GSK (NYSE: GSK) announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA